| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/27/2008 | CN101129484A Traditional Chinese medicine for treating acute psoas aponeurosis damnify |
| 02/27/2008 | CN101129468A Safflower wine |
| 02/27/2008 | CN101129456A Traditional Chinese medicine formulated product used for treating osteosporosis |
| 02/27/2008 | CN101129454A Ointment |
| 02/27/2008 | CN101129448A Compositions for preventing and controlling climacteric syndrome and osteoporosis, and processes for producing the same |
| 02/27/2008 | CN101129353A Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 02/27/2008 | CN101129349A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 02/27/2008 | CN101129325A Whitening speckle-removing spot-removing nourishing powder |
| 02/27/2008 | CN101129321A Vegetable oil varnishing cream |
| 02/27/2008 | CN101129315A Medicine bath shampoo for health preserving and moisturizing skin |
| 02/27/2008 | CN101129309A Traditional Chinese medicine essence cream for dispelling speckle and whitening |
| 02/27/2008 | CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 02/27/2008 | CN100371325C Indenoindole ketone kind compound, its preparation method and use |
| 02/27/2008 | CN100371322C 2-pyrrolidone derivatives as prostanoid agonists |
| 02/27/2008 | CN100371018C Calcitonin composition |
| 02/27/2008 | CN100370973C Traditional Chinese medicinal preparation for treating obstruction of qi in the chest |
| 02/26/2008 | US7335770 Triazine compounds and their analogs, compositions, and methods |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335676 Methods for treating inflammatory conditions or inhibiting JNK |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335672 Vanilloid receptor ligands and their use in treatments |
| 02/26/2008 | US7335663 Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335384 Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith |
| 02/26/2008 | US7335154 Radiotherapy |
| 02/24/2008 | CA2558043A1 Methods of correcting bone mineralization defects, kits therefor and compositions therefor |
| 02/21/2008 | WO2008022182A1 Methods for promoting coupling between bone formation and resorption |
| 02/21/2008 | WO2008020638A1 Therapeutic agent for ligament injury |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020033A1 Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain |
| 02/21/2008 | WO2008019823A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/21/2008 | WO2008000951A3 Urea derivatives of tropane, their preparation and their therapeutic application |
| 02/21/2008 | WO2008000743A3 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 02/21/2008 | WO2007014238A8 Single dose use of cd20-specific binding molecules |
| 02/21/2008 | WO2006032091A3 Herbal composition |
| 02/21/2008 | US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/21/2008 | US20080045597 Dissolves quickly and completely in variety of foods and beverages without negatively impacting taste or texture; bone nutraceutical support |
| 02/21/2008 | US20080045594 Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation |
| 02/21/2008 | US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain |
| 02/21/2008 | US20080045571 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2008 | US20080045557 Compounds and methods to inhibit or augment an inflammatory response |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/21/2008 | US20080045531 Anti-inflammatory medicaments |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045504 Benzonitrile Derivatives to Treat Musculoskeletal Frailty |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045485 Methods of diagnosing synovial disease in a mammal by detecting bacterial DNA in synovial tissues from dogs with inflammatory knee arthritis and degenerative anterior cruciate ligament rupture |
| 02/21/2008 | US20080045465 Phosphole Derivatives Complexed with Metals, and Pharmaceutical Uses Thereof |
| 02/21/2008 | US20080045455 RAGE fusion proteins, formulations, and methods of use thereof |
| 02/21/2008 | US20080045443 Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044544 Milk protein isolate and process for its preparation |
| 02/21/2008 | US20080044476 Mixture of corticosteroid and sodium hyaluronate in aqueous carrier |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044448 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 02/21/2008 | US20080044447 Combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044410 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement; disorders of insulin metabolism |
| 02/21/2008 | US20080044409 Inflammatory mediator antagonists |
| 02/20/2008 | EP1889622A1 Spiropiperidine compound and medicinal use thereof |
| 02/20/2008 | EP1889615A2 Formulations for oral administration with a health promoting effect on the osteoarticular and muscleskeleton apparatus |
| 02/20/2008 | EP1888584A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 02/20/2008 | EP1888527A1 Piperidines for the treatment of chemokine mediated diseases |
| 02/20/2008 | EP1888526A1 Piperidines for the treatment of chemokine mediated diseases |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | CN101128434A Amide derivatives |
| 02/20/2008 | CN101128210A A herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis |
| 02/20/2008 | CN101125206A Diolpolymer-interleukin-1 receptor antagonists conjugate and preparation method and application |
| 02/20/2008 | CN101125201A Medicine composition for treating osteoporosis or preventing bone fracture caused by osteoporosis and its application |
| 02/20/2008 | CN101125196A External applied medicine for treating lumbar vertebra, cervical vertebra and osteoarthrilis |
| 02/20/2008 | CN101125184A Traditional Chinese medicine for treating gout |
| 02/20/2008 | CN101125147A Glucosamine calcium medicine preparation, preparation method and application thereof |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/20/2008 | CN100369627C Bone-setting powder |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332491 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332472 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332276 Administering steroid compound |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |